HKSH News

APAC Lymphoma Summit on Bispecific Antibodies (Sep/Oct 2021)

We are pleased to inform you that the APAC Lymphoma Summit on Bispecific Antibodies is now open for registration!

International experts, Roche scientists and professionals from Taiwan, Hong Kong and Korea will discuss together:

- the science behind the development of bispecific antibodies
- current and future perspectives in R/R DLBCL and FL management
- clinical evidence in real-world settings, and future directions of bispecific antibody therapies.

Webinar 1 - Science Behind Bispecific  
Exploring Novel Agents in T-cell Targeted Therapies: Be Specific on Bispecific Antibodies
Date: Monday, 20 September 2021
Time: 19:00–20:25 (CST/HKT)

Webinar 2 - DLBCL
From Clinical Perspective: The Role of Bispecific Antibodies in Future DLBCL Treatment Algorithm
Date: Saturday, 25 September 2021
Time: 14:00–15:30 (CST/HKT)

Webinar 3 - FL
From Clinical Perspective: The Role of Bispecific Antibodies in Future FL Treatment Algorithm
Date: Thursday, 7 October 2021
Time: 18:00–19:35 (CST/HKT)


Registration link: http://events.mimsit.net/HK-ROC-578/index.html


*CME accreditations will be available for Hong Kong healthcare professionals*

Looking forward to seeing your virtually at the APAC Lymphoma Summit on Bispecific Antibodies!

 

 

APAC Lymphoma Summit on Bispecific Antibodies (Sep/Oct 2021)